One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
CAR T-cell therapy in CKD: preclinical aspiration or promising approach?
doi : 10.1093/ndt/gfag005
Volume 41, Issue 3, March 2026
Trends in nephrology: from ‘translational research’ in animals to research in humans
doi : 10.1093/ndt/gfaf157
International Pediatric Nephrology Association IgA nephropathy guidelines—a commentary
doi : 10.1093/ndt/gfaf247
Myocardial ischaemic syndromes in chronic kidney disease: risky pathways from non-acute to acute events
doi : 10.1093/ndt/gfaf142
Evolving strategies for early diagnosis, proactive prevention and treatment of CKD
doi : 10.1093/ndt/gfaf151
Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications
doi : 10.1093/ndt/gfaf156
Management of monoclonal gammopathy of renal significance: treatment standard
doi : 10.1093/ndt/gfaf254
Trends in home dialysis over the last decade in Europe: an ERA Registry study
doi : 10.1093/ndt/gfaf171
CAKUT subtypes determine the rate of progression to kidney failure—an adult patient cohort study
doi : 10.1093/ndt/gfaf172
Predicting mortality and short-term outcomes of continuous kidney replacement therapies in neonates and infants
doi : 10.1093/ndt/gfaf173
Characteristics and cardio-renal outcomes in patients with CKD receiving guideline-directed medical therapy: insights from DISCOVER CKD
doi : 10.1093/ndt/gfaf175
Albuminuria or proteinuria for response assessment and follow-up in lupus nephritis
doi : 10.1093/ndt/gfaf176
Low dose IL-2 administration prevents but fails to treat experimental autoimmune anti-myeloperoxidase glomerulonephritis
doi : 10.1093/ndt/gfaf178
IGFBP-5/TGF-β1 mediated crosstalk between endothelial and tubular epithelial cells promotes interstitial fibrosis
doi : 10.1093/ndt/gfaf179
Protein profiles and associated biological pathways among different aetiologies of chronic kidney disease: new insights from DAPA-CKD
doi : 10.1093/ndt/gfaf180
Comparing CKD populations with T1D and T2D: a perspective based on the FINE-ONE and FIDELITY populations
doi : 10.1093/ndt/gfaf183
Additive renoprotective effects of oral calcitriol on patients with IgA nephropathy receiving RAS blockers
doi : 10.1093/ndt/gfaf187
Long-term lumasiran therapy final results from a Phase 2 open-label extension study in primary hyperoxaluria
doi : 10.1093/ndt/gfaf188
A consensus statement on the management of vertebral fractures in CKD stages G4–G5D
doi : 10.1093/ndt/gfaf256
Anti-nephrin antibodies in patients with IgA nephropathy and nephrotic syndrome
doi : 10.1093/ndt/gfaf208
Pyrogenic reactions in haemodialysis patients linked to contaminated citrate lock
doi : 10.1093/ndt/gfaf253
